NL-OMON48375已完成不适用
Whole blood thrombin generation, platelet activation test and platelet-monocyte complex formation to predict hypercoagulability in patients with multiple myeloma - Whole blood thrombin generation in patients with multiple myeloma
Synapse Research Institute0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •For all participants (patients and controls):
- •- Subjects of both gender
- •- Age *18
- •- Written informed consent from the subject
- •Patients with Multiple Myeloma:
- •- Stable condition
- •- Diagnosis of Multiple Myeloma
- •- On active treatment with IMiD
- •- Patient of the Meander Medical Center
排除标准
- •For all participants (patients and controls):
- •- Age below 18
- •- Known abnormalities of the coagulation system
- •- Pregnancy
- •- The use of anti-coagulant drugs (low molecular weight heparin (LMWH), vitamin
- •K antagonists (VKAs) and direct oral anticoagulants (DOACs))
- •- Active infection, bleeding or other systemic diseases
- •For controls (relatives: family or no-family):
- •- Active malignancy
- •- Personal history of bleeding or thrombotic events
研究者
相似试验
已完成
不适用
Plasmin generation in tPA-mediated fibrinolysis in patients with stroke1000318410014523CVAstrokeNL-OMON46577Gelre Ziekenhuizen8
已完成
3 期
A Phase 1b/3, Multicenter, Trial of Talimogene Laherparepvec in Combination With Pembrolizumab (MK-3475) for Treatment of Unresectable, Stage IIIB to IVM1c Melanoma (MASTERKEY-265)1) Unresectable stage IIIB to IVM1c melanoma2) Unremoved melanoma (type of skin cancer)10040900NL-OMON50729Amgen15
已完成
不适用
First in Human Study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PPSGG (PN-1007) in anti-MAG neuropathy patients.anti-MAG neuropathyauto-immune10012303NL-OMON49059Polyneuron Pharmaceuticals AG9
已完成
不适用
Verification of preoperative screening for bleeding tendency in patients that report bleeding symptomshemorrhagic diathesisbleeding tendency100644771000533010047075NL-OMON40106niversiteit Maastricht439
已完成
不适用
A first-in-human, randomized, subject-blinded, placebocontrolled, single ascending dose study to investigate the safety, tolerability and pharmacokinetics of MHS552 in healthy volunteersNL-OMON49201ovartis64